Business Standard

Don’t miss the latest developments in business and finance.

Bharat Immunological & Biological Corporation reports standalone net loss of Rs 1.31 crore in the March 2018 quarter

Bs_logoImage
Capital Market
Last Updated : Apr 25 2018 | 5:16 PM IST

Sales decline 64.66% to Rs 21.68 crore

Net loss of Bharat Immunological & Biological Corporation reported to Rs 1.31 crore in the quarter ended March 2018 as against net profit of Rs 4.08 crore during the previous quarter ended March 2017. Sales declined 64.66% to Rs 21.68 crore in the quarter ended March 2018 as against Rs 61.34 crore during the previous quarter ended March 2017.

For the full year,net loss reported to Rs 5.17 crore in the year ended March 2018 as against net profit of Rs 6.75 crore during the previous year ended March 2017. Sales declined 71.98% to Rs 34.80 crore in the year ended March 2018 as against Rs 124.19 crore during the previous year ended March 2017.

ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales21.6861.34 -65 34.80124.19 -72 OPM %-19.7911.17 --24.519.90 - PBDT-4.056.00 PL -7.4910.04 PL PBT-4.105.99 PL -7.909.46 PL NP-1.314.08 PL -5.176.75 PL

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Apr 25 2018 | 5:08 PM IST

Next Story